foxo4-dri senolytic peptide mechanism inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Buy FOXO4-DRI 10mg | Third-Party
Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides FOXO4 DRI The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



